Best Longevity & Peptides Telehealth Brands
Longevity and peptide telehealth covers a loose group of mostly injectable, mostly compounded therapies marketed for energy, recovery, body composition, and healthy aging: NAD+, sermorelin, tesamorelin, glutathione, MIC + B12 'lipo' injections, and off-label use of older drugs such as rapamycin and metformin. The category has grown quickly because these products are cash-pay, subscription-friendly, and outside insurance — not because the clinical evidence has caught up. For most of them, it has not.
The honest summary is that evidence quality varies enormously within this category. Tesamorelin is an FDA-approved drug with randomized trial data for one specific indication. Rapamycin and metformin have strong animal and mechanistic data for aging but little direct human evidence for lifespan or healthspan. NAD+ injections, glutathione injections, and MIC + B12 for weight loss rest largely on small studies, surrogate markers, and extrapolation. A good provider in this category is one that says so plainly, runs baseline labs, and prescribes from a licensed pharmacy.
The regulatory picture matters more here than in any other category we cover. Nearly everything sold is compounded, and the FDA has been actively restricting which peptides compounders may use. Sellers that ship vials labelled 'for research use only' are not telehealth providers at all — they sell unapproved chemicals outside the prescription system, and we do not list them.
Our Pick
Our top-rated longevity & peptides telehealth brand is Measured, scoring 78.7/100 in our independent, category-contextual evaluation. Full rankings and pricing below.
Longevity & Peptides Brands at a Glance
Ranked by our category-contextual score. Prices are the lowest starting price for a longevity & peptides treatment.*
| # | Brand | Score | From | Known for |
|---|---|---|---|---|
| 1 | Measured | 78.7 | $79/mo | Semaglutide, NAD+, sermorelin + 3 more · microdosing |
| 2 | AgelessRx | 77.7 | $25/mo | Rapamycin, metformin, LDN + 4 more |
| 3 | Lavender Sky Health | 73.9 | $105/mo | NAD+, sermorelin, glutathione · sublingual option |
| 4 | Healthspan | 73.3 | $25/mo | Rapamycin, SGLT2 inhibitors, metformin + 4 more |
| 5 | bmiMD | 73.3 | $69/mo | NAD+, sermorelin, MIC-B12 + 1 more · oral option |
| 6 | Shed | 72.9 | $115/mo | MIC-B12 |
| 7 | Direct Meds | 72.6 | $199/mo | Most Transparent Pricing |
| 8 | Lttl | 71.3 | $79/mo | NAD+, sermorelin, glutathione + 3 more · oral option |
| 9 | Yucca Health | 69.9 | $158/mo | NAD+, sermorelin |
| 10 | IVY RX | 69.4 | $175/mo | NAD+, sermorelin, glutathione + 1 more |
| 11 | Enhance.MD | 69.1 | $169/mo | NAD+ |
| 12 | Precision Telemed | 68.8 | $139.99/mo | NAD+, sermorelin |
| 13 | Effecty | 68.8 | $95/mo | NAD+, sermorelin, glutathione + 1 more · oral option |
| 14 | Joi + Blokes | 68.7 | $199/mo | Sermorelin |
| 15 | Niagen Plus | 68.2 | $149/mo | NR (Niagen) |
| 16 | Nu Image Medical | 68 | $84/mo | Sermorelin, NAD+ |
| 17 | Bodybuilding Health+ | 67.9 | $129/mo | NAD+, sermorelin, glutathione + 1 more · oral option |
| 18 | Fella Health | 67.4 | $45/mo | Metformin, rapamycin, NAD+ |
| 19 | MyDrHank | 67.3 | $103/mo | NAD+, sermorelin, glutathione |
| 20 | Tuyo Health | 67.1 | $145/mo | Sermorelin |
| 21 | yourEra | 67 | $150/mo | NAD+, sermorelin |
| 22 | Heally | 66 | $75/mo | Rapamycin, NAD+, sermorelin + 2 more |
| 23 | Raeliva | 66 | $117/mo | NAD+, sermorelin, glutathione |
| 24 | Gala Health | 65.9 | $118/mo | NAD+, sermorelin |
| 25 | ReadyRx | 65.9 | $80/mo | Sermorelin, NAD+, glutathione + 1 more · compounded |
| 26 | Brightmeds | 65.8 | $99/mo | Sermorelin, NAD+, glutathione |
| 27 | Ozari Health | 65.8 | $100/mo | NAD+, glutathione, lipo-C + 1 more |
| 28 | Pallas Health | 65.5 | $139/mo | NAD+, sermorelin, glutathione · compounded |
| 29 | Invigor Medical | 65.4 | $155/mo | NAD+, sermorelin, glutathione + 1 more · oral option |
| 30 | He & She MD | 64.9 | $100/mo | NAD+, sermorelin, glutathione + 1 more |
| 31 | UrWay Health | 64.8 | $179/mo | NAD+, glutathione, sermorelin · compounded |
| 32 | AlphaMD | 64.7 | $130/mo | Sermorelin, NAD+ |
| 33 | RNK Health | 63.6 | $97/mo | NAD+, sermorelin, MIC-B12 |
| 34 | JRNYS | 63.5 | $149/mo | NAD+, glutathione |
| 35 | Feel30 | 63 | $149/mo | Sermorelin |
| 36 | Sermorelin.com | 62.5 | $149/mo | Sermorelin · compounded · sublingual option |
| 37 | Remote Pharmacy | 61.9 | $119/mo | NAD+ |
| 38 | ProlongMD | 61.8 | $179/mo | Sermorelin, NAD+ |
| 39 | BiltRx | 61.7 | $97/mo | Sermorelin, tesamorelin, NAD+ + 2 more |
| 40 | System Labs | 61.7 | $89/mo | NAD+, glutathione, sermorelin + 1 more · oral option |
| 41 | Luvo Health | 61 | $145/mo | NAD+, sermorelin, MIC-B12 |
| 42 | Oak Longevity | 60.7 | $99/mo | NAD+, sermorelin |
| 43 | LIV Body | 60.3 | $129/mo | NAD+ |
| 44 | Eden | 60.2 | $215/mo | NAD+ |
| 45 | RxSpan MD | 59.3 | $100/mo | NAD+, sermorelin, glutathione |
| 46 | InsideTracker | 59.3 | $28/mo | Lab testing |
| 47 | FeelGood | 58.3 | — | — |
| 48 | MadeMed | 58.1 | $129/mo | Sermorelin, NAD+ · oral option |
| 49 | WellMaleRx | 57.6 | $79.5/mo | NAD+, glutathione, MIC-B12 |
| 50 | Taurus Meds | 57.5 | $129/mo | NAD+, sermorelin, glutathione |
| 51 | Telos Rx | 57.3 | $116/mo | NAD+, sermorelin |
| 52 | Marek Health | 56.9 | — | Therapy |
| 53 | Synergy Rx | 56.6 | $109/mo | NAD+, sermorelin, glutathione + 1 more |
| 54 | Wellmedr | 56.1 | $120/mo | NAD+ |
| 55 | Embody | 55.9 | $99/mo | NAD+, sermorelin |
| 56 | Viking Man | 54.4 | $40/mo | NAD+ |
| 57 | Renew Youth | 53.9 | — | Therapy |
| 58 | Breeze Meds | 53.8 | $169/mo | NAD+ |
| 59 | Sprout Health | 53.8 | $199/mo | NAD+ · compounded |
| 60 | DudeMeds | 52.7 | — | NAD+ |
| 61 | Syra Rx | 52.7 | $150/mo | Sermorelin, tesamorelin, NAD+ · compounded |
| 62 | Care Bare Rx | 51.1 | $199/mo | NAD+ |
| 63 | Wellorithm | 50.4 | — | — |
| 64 | CoreAge Rx | 49.8 | $93/mo | NAD+, sermorelin |
| 65 | Elite HRT | 48.9 | $325/mo | NAD+ · compounded |
| 66 | Ways2Well | 45.3 | $125/mo | Lab testing, doctor visits, therapy |
What to Look For in a Longevity & Peptides Provider
A prescription from a licensed clinician, filled by a licensed pharmacy
Every legitimate product in this category requires a prescriber evaluation and is dispensed by a state-licensed 503A compounding pharmacy or a registered 503B outsourcing facility. 'Research peptide' websites that sell vials labelled 'not for human use' without a prescription are selling unregulated chemicals with no sterility, potency, or identity guarantees — no clinician, no pharmacy, no accountability.
503A vs. 503B sourcing
503A pharmacies compound patient-specific prescriptions and are overseen primarily by state boards of pharmacy. 503B outsourcing facilities register with the FDA, follow current good manufacturing practice (cGMP), and are inspected by the agency. Both are legal routes; 503B generally means more consistent quality control for sterile injectables. Providers that name their pharmacy and its type are easier to hold to account.
Which peptides are actually compoundable
In 2023 the FDA placed a number of popular peptides — including BPC-157, thymosin beta-4 fragments (TB-500), and several growth-hormone secretagogues — in Category 2 of its 503A bulk-substance list, meaning the agency identified significant safety risks and pharmacies should not compound them. Several nominations were later withdrawn and those substances removed from Category 2, which did not make them compoundable: a substance on no list is generally ineligible for 503A compounding unless it is a component of an approved drug or has a USP monograph. A provider openly prescribing BPC-157 injections is operating outside that framework.
Baseline labs and a defined goal
Growth-hormone secretagogues (sermorelin, tesamorelin) should be preceded by IGF-1 and glucose testing and followed up with repeat labs. Rapamycin and metformin warrant lipid, glucose, kidney, and blood-count monitoring. A program that ships injections with no labs and no stated clinical goal is selling a product, not providing care.
Honest evidence framing
Look for providers that distinguish FDA-approved uses from off-label and wellness uses, and that describe expected effects in measured terms. Claims of 'reversing aging', 'cellular repair', or guaranteed energy gains are marketing language that no trial in this category supports.
All-in monthly cost
Pricing commonly splits into a membership or consult fee, the medication, supplies (syringes, bacteriostatic water), and labs. Injectables in this category typically run from roughly $100 to $400 per month each, and stacked protocols multiply quickly. Price the full year, including labs, before committing.
How we rank these brands
Rankings on this page use a category-contextual version of our scoring: trust & safety (30%), value (25%), experience (20%), product depth within longevity & peptides (15%), and reputation (10%), with a small bonus for category specialists. Scores come from independent research — website analysis, regulatory records, patient reviews, and pricing verification. Green ✓ badges are earned from our data by published rules; gold badges are editor's awards. Read our full methodology and badge rules.
Longevity & Peptides Telehealth — Frequently Asked Questions
Is there good evidence that NAD+ injections slow aging?
▾
Not in humans yet. NAD+ levels decline with age, and raising them extends healthspan in some animal models. Human studies — mostly of oral precursors such as NR and NMN — show that blood NAD+ levels rise, but effects on clinical outcomes have been small or inconsistent. Injectable and IV NAD+ have very little controlled trial data. It is reasonable to treat NAD+ as an experimental wellness therapy rather than an established treatment.
What is the difference between sermorelin, tesamorelin, and growth hormone?
▾
All three act on the growth hormone axis. Recombinant human growth hormone (somatropin) replaces GH directly and is tightly regulated — prescribing it for anti-aging is not a permitted use under federal law. Sermorelin and tesamorelin are GHRH analogues that stimulate the pituitary to release its own GH. Tesamorelin (Egrifta) is FDA-approved to reduce abdominal fat in HIV-associated lipodystrophy; sermorelin's branded product was discontinued in 2008 and it is now available only compounded. Neither is approved for anti-aging.
Why can't I get BPC-157 from a telehealth provider?
▾
Because the FDA has told compounding pharmacies not to make it. BPC-157 has no approved drug, no USP monograph, and minimal human safety data, and the agency listed it among bulk substances raising significant safety concerns in 2023. Sites selling it as a 'research chemical' are not dispensing medicine, and product-testing surveys of such sites have repeatedly found mislabelled potency and contamination.
Is rapamycin for longevity legitimate?
▾
Rapamycin (sirolimus) is an FDA-approved transplant drug. It is the most consistently effective lifespan-extending compound in mouse studies, which is why longevity clinicians prescribe it off-label in low, intermittent doses. Human evidence is early: small trials suggest intermittent low doses are reasonably tolerated, but no study has shown it extends human lifespan or healthspan. It is a legal off-label prescription, and it is also an immunosuppressant that requires monitoring.
What does longevity telehealth typically cost?
▾
Single injectable programs (NAD+, sermorelin, glutathione) typically run about $100–400 per month. Oral off-label drugs such as rapamycin, metformin, or low-dose naltrexone are much cheaper as medications — often under $50 per month — with most of the cost in membership and lab fees. Compounded tesamorelin commonly costs several hundred dollars per month; branded Egrifta costs thousands at list price. Insurance rarely covers any of these for longevity use.
Are compounded peptides safe?
▾
Compounded medications are not FDA-approved, so no regulator has reviewed their safety and effectiveness as finished products. Risk depends heavily on the pharmacy: sterile compounding errors (contamination, wrong potency) are the main hazard for injectables. Products from a licensed pharmacy under a real prescription carry far less risk than gray-market vials, but they still lack the evidence base and manufacturing oversight of approved drugs.